I am a medicinal chemist and drug discovery leader interested in working collaboratively with academics and industry in order to translate basic neurodegeneration research into potential new treatments. The Alzheimer?s Research UK Cambridge Drug Discovery Institute seeks to generate new validated targets for neurodegenerative disorders and to identify chemical probes and lead compounds for drug development. Our overall objective is to fast-track promising academic science into benefits for people with dementia as quickly as possible. We are focusing on neurodegenerative diseases that cause dementia. These may include Alzheimer?s, vascular dementia, dementia with Lewy bodies, frontotemporal dementia, Parkinson?s dementia and Huntington?s disease. We may also research diseases that share some of the fundamental biological changes involved in particular dementias e.g. motor neurone disease.